Semaglutide is a GLP-1 receptor agonist that mimics the GLP-1 hormone - slowing gastric emptying, reducing appetite, triggering glucose-dependent insulin release, and suppressing glucagon
Making healthy choices without feeling limited or unsatisfied
Imputation was performed using a linear regression model, with sex, baseline BMI and timing of last observation as factors, and baseline value and last observation value as covariates
By merging components of four different hormones into a single drug, researchers aim to combat obesity while also tackling related conditions such as type 2 diabetes, cancer, and cardiovascular disease
PMC Cognitive Function and Neurological Research Robillard JM, et al